 |
|
Apolipoprotein E  4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias
Robert Barber, MRCPsych;
Anil Gholkar, FRCR;
Philip Scheltens, MD;
Clive Ballard, MD;
Ian G. McKeith, MD;
Chris M. Morris, PhD;
John T. O'Brien, DM
Arch Neurol. 1999;56:961-965.
Objective To examine the relationship between the apolipoprotein E (APOE)  4 genotype, medial temporal lobe atrophy, and white matter hyperintensities on magnetic resonance imaging in late-life dementias.
Design Structural magnetic resonance imaging study using T2-weighted and proton density–weighted axial scans and T1-weighted coronal scans.
Setting Community-dwelling population of elderly patients prospectively chosen from a clinical case register of consecutive referrals to old age psychiatry services.
Subjects Twenty-five subjects with Alzheimer disease (by criteria of the National Institute of Neurological and Communication Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; mean age, 77.8 years), 22 subjects with dementia with Lewy bodies (consensus criteria; mean age, 77.2 years), and 24 subjects with vascular dementia (by criteria of the National Institute of Neurological Disorders and Stroke and the Association International pour la Recherche et l'Enseignement en Neurosciences; mean age, 76.9 years) were selected. Subjects were well matched for age, sex, duration of illness, and cognitive function.
Main Outcome Measures The APOE genotype was determined using the polymerase chain reaction method, and medial temporal lobe atrophy and white matter hyperintensities (periventricular and deep white matter) were visually rated using standardized scales.
Results In all subjects with dementia, no significant associations were noted between APOE 4 status and medial temporal lobe atrophy (mean score: 0 4=4.5, 1 4=4.5, and 2 4=4.3; P=.90), periventricular hyperintensities (0 4=3.3, 1 4=3.1, and 2 4=2.9; P=.83), and white matter hyperintensities (0 4=5.3, 1 4=4.9, and 2 4=4.9; P=.79).
Conclusions The APOE 4 allele does not determine medial temporal lobe atrophy or white matter lesions, as measured by magnetic resonance imaging in patients with Alzheimer disease, vascular dementia, or dementia with Lewy bodies. Although APOE 4 may modify the risk for acquiring dementia, this finding provides further evidence that APOE 4 does not influence pathological processes thereafter.
From the Institute for the Health of the Elderly (Drs Barber, McKeith, and O'Brien), the Medical Research Council Neurochemical Pathology Unit (Drs Ballard and Morris), and the Department of Neuroradiology (Dr Gholkar), Newcastle General Hospital, Newcastle upon Tyne, England; and the Department of Neurology, Academisch Ziekenhuis Free University Hospital, Amsterdam, the Netherlands (Dr Scheltens).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(8):1037-1038.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects * Supplemental References
Paternoster et al.
Stroke 2009;40:2020-2026.
ABSTRACT
| FULL TEXT
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Drzezga et al.
Neurology 2009;72:1487-1494.
ABSTRACT
| FULL TEXT
Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis
Burton et al.
Brain 2009;132:195-203.
ABSTRACT
| FULL TEXT
Role of imaging techniques in the diagnosis of dementia
O'BRIEN
Br. J. Radiol. 2007;80:S71-S77.
ABSTRACT
| FULL TEXT
Biomarkers of cerebrovascular disease in dementia
MILLS et al.
Br. J. Radiol. 2007;80:S128-S145.
ABSTRACT
| FULL TEXT
APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Martins et al.
Neurology 2005;65:1888-1893.
ABSTRACT
| FULL TEXT
Cerebral White Matter Changes and Geriatric Syndromes: Is There a Link?
Kuo and Lipsitz
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M818-M826.
ABSTRACT
| FULL TEXT
Midlife Blood Pressure and the Risk of Hippocampal Atrophy: The Honolulu Asia Aging Study
Korf et al.
Hypertension 2004;44:29-34.
ABSTRACT
| FULL TEXT
Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease
Tian et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:696-699.
ABSTRACT
| FULL TEXT
Contribution of cerebral amyloid angiopathy to Alzheimer's disease
Love
J. Neurol. Neurosurg. Psychiatry 2004;75:1-4.
FULL TEXT
Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease
Hogervorst et al.
Arch Neurol 2002;59:787-793.
ABSTRACT
| FULL TEXT
The effect of APOE {epsilon}4 allele on cerebral glucose metabolism in AD is a function of age at onset
Hirono et al.
Neurology 2002;58:743-750.
ABSTRACT
| FULL TEXT
Temporal Lobe Morphology in Normal Aging and Traumatic Brain Injury
Bigler et al.
Am. J. Neuroradiol. 2002;23:255-266.
ABSTRACT
| FULL TEXT
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
Hsu et al.
J Geriatr Psychiatry Neurol 2001;14:145-166.
ABSTRACT
Neuropsychiatric Significance of Subcortical Hyperintensity
Campbell and Coffey
J. Neuropsychiatry Clin. Neurosi. 2001;13:261-288.
FULL TEXT
Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype
Bigler et al.
Am. J. Neuroradiol. 2000;21:1857-1868.
ABSTRACT
| FULL TEXT
Effect of the Apolipoprotein E {epsilon}4 Allele on White Matter Hyperintensities in Dementia
Hirono et al.
Stroke 2000;31:1263-1268.
ABSTRACT
| FULL TEXT
MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia
Barber et al.
Neurology 2000;54:1304-1309.
ABSTRACT
| FULL TEXT
|
